{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T03:40:25Z","timestamp":1769312425644,"version":"3.49.0"},"reference-count":50,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.3892\/etm.2014.2039","type":"journal-article","created":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T09:21:20Z","timestamp":1414660880000},"page":"232-238","source":"Crossref","is-referenced-by-count":16,"title":["Clinical diagnostic utility of CA 15-3 for the diagnosis of malignant pleural effusion: A meta-analysis"],"prefix":"10.3892","volume":"9","author":[{"given":"QIANG","family":"WU","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MIN","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHU","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LU","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XINGTING","family":"GU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FENG","family":"XU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,10,30]]},"reference":[{"key":"key20180108130303_b1-etm-09-01-0232","first-page":"1987","article-title":"Management of malignant pleural effusions","volume":"162","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"key20180108130303_b2-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1055\/s-0030-1269831","article-title":"Management of the patient with a malignant pleural effusion","volume":"31","author":"Heffner","year":"2010","journal-title":"Semin Respir Crit Care Med"},{"key":"key20180108130303_b3-etm-09-01-0232","first-page":"133","article-title":"Pleural effusion related to metastatic malignancies","volume-title":"Pleural Diseases","author":"Light","year":"2001","edition":"4th edition"},{"key":"key20180108130303_b4-etm-09-01-0232","first-page":"296","article-title":"Management of malignant pleural effusions","volume":"11","author":"Bennett","year":"2005","journal-title":"Curr Opin Pulm Med"},{"key":"key20180108130303_b5-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0025-6196(12)60212-2","article-title":"Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases","volume":"60","author":"Prakash","year":"1985","journal-title":"Mayo Clin Proc"},{"key":"key20180108130303_b6-etm-09-01-0232","first-page":"320","article-title":"Diagnostic efficacy of pleural biopsy as compared with that of pleural fluid examination","volume":"4","author":"Nance","year":"1991","journal-title":"Mod Pathol"},{"key":"key20180108130303_b7-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/COC.0b013e3181aacbbf","article-title":"Diagnosis and treatment of malignant pleural effusion: a systematic literature review and new approaches","volume":"33","author":"Lombardi","year":"2010","journal-title":"Am J Clin Oncol"},{"key":"key20180108130303_b8-etm-09-01-0232","first-page":"73","article-title":"Tumor markers in clinical oncology","volume":"38","author":"Novakovi\u0107","year":"2004","journal-title":"Radiol Oncol"},{"key":"key20180108130303_b9-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0002-9610(99)80257-8","article-title":"Diagnosis and management of malignant pleural effusions","volume":"170","author":"Fenton","year":"1995","journal-title":"Am J Surg"},{"key":"key20180108130303_b10-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1378\/chest.126.6.1757","article-title":"Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions","volume":"126","author":"Porcel","year":"2004","journal-title":"Chest"},{"key":"key20180108130303_b11-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1378\/chest.126.6.1721","article-title":"Tumor markers in undiagnosed pleural effusions","volume":"126","author":"Light","year":"2004","journal-title":"Chest"},{"issue":"Suppl 2","key":"key20180108130303_b12-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/S0169-5002(01)00347-6","article-title":"Lung tumor markers of cytokeratin origin: an overview","volume":"34","author":"Buccheri","year":"2001","journal-title":"Lung Cancer"},{"key":"key20180108130303_b13-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1183\/09031936.93.01040341","article-title":"Diagnostic value of cancer antigen 15-3(CA 15-3) detected by monoclonal antibodies (115D8 and DF3) in exudative pleural effusions","volume":"1","author":"Shimokata","year":"1988","journal-title":"Eur Respir J"},{"key":"key20180108130303_b14-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/172460089100600206","article-title":"Tumour associated antigens CA 15-3 and CA 125 in ovarian cancer","volume":"6","author":"Lotzniker","year":"1991","journal-title":"Int J Bid Markers"},{"key":"key20180108130303_b15-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1183\/09031936.96.09010017","article-title":"CEA, CA15-3 and CYFRA21-1 in serum and pleural fluid of patients with pleural effusions","volume":"9","author":"Romero","year":"1996","journal-title":"Eur Respir J"},{"key":"key20180108130303_b16-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/(SICI)1097-0142(19960815)78:4<736::AID-CNCR7>3.0.CO;2-C","article-title":"Diagnostic value of CA 72-4, carcinoembrynic antigen, CA 15-3 and CA 19-9 assay in pleural fluid: A study of 207 patients","volume":"78","author":"Villena","year":"1996","journal-title":"Cancer"},{"key":"key20180108130303_b17-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/sj.bjc.6690807","article-title":"Evaluation of seven tumor markers in pleural fluid for the diagnosis of malignant effusions","volume":"81","author":"Mi\u00e9doug\u00e9","year":"1999","journal-title":"Br J Cancer"},{"key":"key20180108130303_b18-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/1097-0142(20000825)90:4<230::AID-CNCR5>3.0.CO;2-6","article-title":"Diagnostic value of a second generation CA 15-3 antibody to detect adenocarcinoma in body cavity effusions","volume":"90","author":"Zimmerman","year":"2000","journal-title":"Cancer Cytopathol"},{"key":"key20180108130303_b19-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0169-5002(00)00153-7","article-title":"Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions","volume":"31","author":"Alata\u015f","year":"2001","journal-title":"Lung Cancer"},{"key":"key20180108130303_b20-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0169-5002(03)00120-X","article-title":"Diagnostic value of CA 549 in pleural fluid, Comparison with CEA, CA 15-3 and CA 72-4","volume":"40","author":"Villena","year":"2003","journal-title":"Lung Cancer"},{"key":"key20180108130303_b21-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1378\/chest.126.6.1757","article-title":"Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohy-drate antigen 15-3 and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions","volume":"126","author":"Porcel","year":"2004","journal-title":"Chest"},{"key":"key20180108130303_b22-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1368-5031.2004.0015.x","article-title":"Diagnostic value of tumoural markers in pleural effusions","volume":"58","author":"Ust\u00fcn","year":"2004","journal-title":"Int J Clin Pract"},{"key":"key20180108130303_b23-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/BF02893857","article-title":"Diagnostic value of tumor markers for differentiating malignant and benign pleural effusions of Iranian patients","volume":"11","author":"Ghayumi","year":"2005","journal-title":"Pathol Oncol Res"},{"key":"key20180108130303_b24-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1634\/theoncologist.10-7-501","article-title":"Diagnostic value of CYFRA21-1, CEA, CA 19-9, CA 15-3 and CA 125 assays in pleural effusions: analysis of 116 case and review of the literature","volume":"10","author":"Shitrit","year":"2005","journal-title":"Oncologist"},{"key":"key20180108130303_b25-etm-09-01-0232","first-page":"1921","article-title":"Tumor markers in pleural effusions","volume":"27","author":"Topolcan","year":"2007","journal-title":"Anticancer Res"},{"key":"key20180108130303_b26-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"165","DOI":"10.29333\/ejgm\/82523","article-title":"Diagnostic value of CEA, CA 19-9, CA 125 and CA 15-3 levels in malignant pleural fluids","volume":"4","author":"Pa\u015fao\u011flu","year":"2007","journal-title":"Eur J Gen Med"},{"key":"key20180108130303_b27-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1590\/S1806-37132007000200013","article-title":"Evaluation of serum and pleural levels of the tumor markers CEA, CYFRA21-1 and CA 15-3 in patients with pleural effusion","volume":"33","author":"Wagner","year":"2007","journal-title":"J Bras Pneumol"},{"key":"key20180108130303_b28-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1742-1241.2006.01111.x","article-title":"Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions","volume":"61","author":"Li","year":"2007","journal-title":"Int J Clin Pract"},{"key":"key20180108130303_b29-etm-09-01-0232","first-page":"2947","article-title":"Clinical utility of a combination of tumor markers in the diagnosis of malignant pleural effusions","volume":"28","author":"Gaspar","year":"2008","journal-title":"Anticancer Res"},{"key":"key20180108130303_b30-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/sj.bjc.6604340","article-title":"Overexpression and altered glycosylation of MUC1 in malignant mesothelioma","volume":"98","author":"Creaney","year":"2008","journal-title":"Br J Cancer"},{"key":"key20180108130303_b31-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3892\/ol_00000082","article-title":"Diagnostic value of carbohydrate antigens in supernatants and sediments of pleural effusions","volume":"1","author":"Terracciano","year":"2010","journal-title":"Oncol Lett"},{"key":"key20180108130303_b32-etm-09-01-0232","first-page":"146","article-title":"Evaluation of pleural fluid levels and Pleural-Serum Ratio of the tumor markers CEA, CA 15-3, CA 19-9, CA 72-4, CA 125 and CYFRA 21-1 in the diagnosis of malignant pleural effusion","volume":"15","author":"Antonangelo","year":"2010","journal-title":"Braz J Biol"},{"key":"key20180108130303_b33-etm-09-01-0232","first-page":"499","article-title":"Pleural cyfra 21-1 and CA 15-3 in differentiation of malignant from benign pleural effusions","volume":"9","author":"Farag","year":"2012","journal-title":"Life Sci J"},{"key":"key20180108130303_b34-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2288-3-25","article-title":"The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews","volume":"3","author":"Whiting","year":"2003","journal-title":"BMC Med Res Methodol"},{"key":"key20180108130303_b35-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijcard.2009.05.063","article-title":"Diagnostic accuracy meta-analysis: a review of the basic principles of interpretation and application","volume":"140","author":"Jones","year":"2010","journal-title":"Int J Cardiol"},{"key":"key20180108130303_b36-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/sim.4780121403","article-title":"Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations","volume":"12","author":"Moses","year":"1993","journal-title":"Stat Med"},{"key":"key20180108130303_b37-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1067\/mem.2001.114903","article-title":"Diagnosing acute cardiac ischemia in the emergency department: a systematic review of the accuracy and clinical effect of current technologies","volume":"37","author":"Lau","year":"2001","journal-title":"Ann Emerg Med"},{"key":"key20180108130303_b38-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"667","DOI":"10.7326\/0003-4819-120-8-199404150-00008","article-title":"Guidelines for meta-analyses evaluating diagnostic tests","volume":"120","author":"Irwig","year":"1994","journal-title":"Ann Intern Med"},{"key":"key20180108130303_b39-etm-09-01-0232","first-page":"675","article-title":"Meta-analyses of studies of the diagnostic accuracy of laboratory tests: a review of the concepts and methods","volume":"122","author":"Vamvakas","year":"1998","journal-title":"Arch Pathol Lab Med"},{"key":"key20180108130303_b40-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jclinepi.2003.09.017","article-title":"The conditional relative odds ratio provided less biased results for comparing diagnostic test accuracy in meta-analyses","volume":"57","author":"Suzuki","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"key20180108130303_b41-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2288-5-20","article-title":"How does study quality affect the results of a diagnostic meta-analysis?","volume":"5","author":"Westwood","year":"2005","journal-title":"BMC Med Res Methodol"},{"key":"key20180108130303_b42-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta7270","article-title":"Evaluating non-randomised intervention studies","volume":"7","author":"Deeks","year":"2003","journal-title":"Health Technol Assess"},{"key":"key20180108130303_b43-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ejim.2008.11.009","article-title":"High levels of tumor markers in pleural fluid correlate with poor survival in patients with adenocarcinomatous or squamous malignant effusions","volume":"20","author":"Bielsa","year":"2009","journal-title":"Eur J Intern Med"},{"key":"key20180108130303_b44-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000050639","article-title":"Independent factors predict supranormal CA 15-3 serum levels in advanced breast cancer patients at first disease relapse","volume":"22","author":"Tampellini","year":"2001","journal-title":"Tumor Biol"},{"key":"key20180108130303_b45-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00000421-199706000-00007","article-title":"Tumor markers in the diagnosis of malignant serous effusions","volume":"20","author":"Cascinu","year":"1997","journal-title":"Am J Clin Oncol"},{"key":"key20180108130303_b46-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/sim.4780121403","article-title":"Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations","volume":"12","author":"Moses","year":"1993","journal-title":"Stat Med"},{"key":"key20180108130303_b47-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0895-4356(03)00177-X","article-title":"The diagnostic odds ratio: a single indicator of test performance","volume":"56","author":"Glas","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"key20180108130303_b48-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/9780470693926.ch14","article-title":"Systematic reviews of evaluations of diagnostic and screening tests","volume-title":"Systematic Reviews in Health Care: Meta-analysis in Context","author":"Deeks","year":"2001","edition":"2nd edition"},{"key":"key20180108130303_b49-etm-09-01-0232","first-page":"121","article-title":"Diagnostic tests","volume-title":"Users\u2019 Guides to the Medical Literature: A Manual for Evidence-based Clinical Practice","author":"Jaeschke","year":"2002"},{"key":"key20180108130303_b50-etm-09-01-0232","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/thx.2007.077958","article-title":"Diagnostic accuracy of tumor markers for malignant pleural effusion: a meta-analysis","volume":"63","author":"Liang","year":"2008","journal-title":"Thorax"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2014.2039\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T18:13:31Z","timestamp":1689617611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2014.2039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,30]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,10,30]]},"published-print":{"date-parts":[[2015,1]]}},"alternative-id":["10.3892\/etm.2014.2039"],"URL":"https:\/\/doi.org\/10.3892\/etm.2014.2039","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,30]]}}}